This suggests that Nrf2-dependent antioxidant target genes, including HO-1 and phase II antioxidant enzymes (e.g., NQO-1, GST, GCL, catalase, and SOD2), may suppress AMD pathogenesis. The gene discussed is NFE2L2; the disease is age-related macular degeneration.